These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22366569)

  • 1. Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease.
    Hezzell MJ; Boswood A; Moonarmart W; Elliott J
    J Vet Cardiol; 2012 Mar; 14(1):269-79. PubMed ID: 22366569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic predictors of survival in dogs with myxomatous mitral valve disease.
    Sargent J; Muzzi R; Mukherjee R; Somarathne S; Schranz K; Stephenson H; Connolly D; Brodbelt D; Fuentes VL
    J Vet Cardiol; 2015 Mar; 17(1):1-12. PubMed ID: 25586168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
    Morgan KRS; Monteith G; Raheb S; Colpitts M; Fonfara S
    Vet J; 2020 Sep; 263():105518. PubMed ID: 32928487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Doppler and strain imaging in dogs with myxomatous mitral valve disease in different stages of congestive heart failure.
    Tidholm A; Ljungvall I; Höglund K; Westling AB; Häggström J
    J Vet Intern Med; 2009; 23(6):1197-207. PubMed ID: 19909428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
    Ljungvall I; Rajamäki MM; Crosara S; Olsen LH; Kvart C; Borgarelli M; Höglund K; Häggström J
    Am J Vet Res; 2011 Aug; 72(8):1022-8. PubMed ID: 21801058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of signal analysis of heart sounds and murmurs to assess severity of mitral valve regurgitation attributable to myxomatous mitral valve disease in dogs.
    Ljungvall I; Ahlstrom C; Höglund K; Hult P; Kvart C; Borgarelli M; Ask P; Häggström J
    Am J Vet Res; 2009 May; 70(5):604-13. PubMed ID: 19405899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial ejection fraction assessed by real-time 3-dimensional echocardiography in normal dogs and dogs with myxomatous mitral valve disease.
    Tidholm A; Höglund K; Häggström J; Bodegård-Westling A; Ljungvall I
    J Vet Intern Med; 2013; 27(4):884-9. PubMed ID: 23731204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between N-terminal procollagen type III, fibrosis and echocardiographic indices in dogs that died due to myxomatous mitral valve disease.
    Hezzell MJ; Falk T; Olsen LH; Boswood A; Elliott J
    J Vet Cardiol; 2014 Dec; 16(4):257-64. PubMed ID: 25292459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of treatment on respiratory rate, serum natriuretic peptide concentration, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure secondary to degenerative mitral valve disease and dilated cardiomyopathy.
    Schober KE; Hart TM; Stern JA; Li X; Samii VF; Zekas LJ; Scansen BA; Bonagura JD
    J Am Vet Med Assoc; 2011 Aug; 239(4):468-79. PubMed ID: 21838584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
    Boswood A; Häggström J; Gordon SG; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Watson P
    J Vet Intern Med; 2016 Nov; 30(6):1765-1779. PubMed ID: 27678080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases.
    de Andrade JN; Christopher Orton E; Boon J; Nishimori CT; Olivaes C; Camacho AA
    J Vet Cardiol; 2011 Sep; 13(3):197-201. PubMed ID: 21824833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve disease.
    Zois NE; Olsen NT; Moesgaard SG; Rasmussen CE; Falk T; Häggström J; Pedersen HD; Møller JE; Olsen LH
    J Vet Intern Med; 2013; 27(4):875-83. PubMed ID: 23731222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
    Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
    Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
    Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
    J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
    Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of mitral regurgitation in dogs: comparison of results of echocardiography with magnetic resonance imaging.
    Sargent J; Connolly DJ; Watts V; Mõtsküla P; Volk HA; Lamb CR; Fuentes VL
    J Small Anim Pract; 2015 Nov; 56(11):641-50. PubMed ID: 26473746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K; Kawamoto S; Osuga T; Morita T; Sasaki N; Morishita K; Ohta H; Takiguchi M
    J Vet Intern Med; 2017 Mar; 31(2):316-325. PubMed ID: 28145607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
    Caivano D; Rishniw M; Birettoni F; Patata V; Giorgi ME; Porciello F
    J Vet Cardiol; 2018 Apr; 20(2):102-114. PubMed ID: 29459124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs.
    Vezzosi T; Grosso G; Tognetti R; Meucci V; Patata V; Marchesotti F; Domenech O
    J Vet Intern Med; 2021 May; 35(3):1238-1244. PubMed ID: 33951235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease.
    Tidholm A; Höglund K; Häggström J; Ljungvall I
    J Vet Intern Med; 2015; 29(6):1510-7. PubMed ID: 26365438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.